Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines

Area of Science:

• Hematology
• Internal Medicine
• Critical Care Medicine

Background:

• Three recent guidelines address the diagnosis and treatment of disseminated intravascular coagulation (DIC) in adults.
• Significant variations exist in recommendations, necessitating harmonization for clinical practice.
• Disseminated intravascular coagulation (DIC) is a complex syndrome with high morbidity and mortality.

Purpose of the Study:

• To harmonize recommendations from recent adult disseminated intravascular coagulation (DIC) guidelines using a modified GRADE system.
• To provide evidence-based consensus on DIC diagnosis and management.
• To clarify optimal therapeutic strategies for DIC.

Main Methods:

• A modified GRADE (Grading of Recommendations Assessment, Development and Evaluation) system was employed.
• Recommendations were synthesized and harmonized across multiple published guidelines.
• Evidence quality was assessed using established criteria.

Main Results:

• Diagnosis of DIC using global coagulation tests correlates with clinical observations and outcomes.
• Treatment of the underlying condition is the cornerstone of DIC management.
• Transfusions are generally reserved for bleeding patients; therapeutic heparin for thrombosis, prophylactic for critically ill non-bleeding patients.
• Antifibrinolytics are generally not recommended, except in specific hyperfibrinolytic states like leukemia or trauma with severe bleeding.

Conclusions:

• Harmonized recommendations provide a clearer approach to DIC diagnosis and treatment.
• Treatment strategies should be tailored to the specific clinical presentation of DIC, including bleeding risk and thrombotic or hyperfibrinolytic states.
• Further research, particularly randomized controlled trials, is needed to refine DIC management, including the roles of antithrombin and recombinant thrombomodulin.